Neonatal Thrombocytopenia as a Presenting Finding in de novo Pyruvate Kinase Deficiency

Neonatology. 2023;120(5):661-665. doi: 10.1159/000531242. Epub 2023 Jul 20.

Abstract

Thrombocytopenia is a common laboratory abnormality encountered in critically ill neonates. The broad differential for thrombocytopenia, and its association with potentially severe neonatal pathology, often presents a diagnostic dilemma prompting extensive evaluation. Hemolysis due to red cell enzymopathies is a rare cause of neonatal thrombocytopenia that is typically brief and self-limiting. Here, we present a case of thrombocytopenia, refractory to transfusion, associated with anemia and hyperbilirubinemia in a neonate with pyruvate kinase deficiency (PKD) arising from compound heterozygous PKLR mutations. The nature of the thrombocytopenia in this patient created considerable diagnostic uncertainty, which was ultimately resolved by whole-exome sequencing. This case emphasizes that inherited red cell defects, such as PKD, are important to consider in cases of neonatal thrombocytopenia.

Keywords: Hemolysis; Hyperbilirubinemia; Red cell enzymopathy; Thrombocytopenia; Whole-exome sequencing.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anemia*
  • Anemia, Hemolytic, Congenital Nonspherocytic* / complications
  • Anemia, Hemolytic, Congenital Nonspherocytic* / diagnosis
  • Anemia, Hemolytic, Congenital Nonspherocytic* / genetics
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Pyruvate Kinase / genetics
  • Pyruvate Metabolism, Inborn Errors* / complications
  • Pyruvate Metabolism, Inborn Errors* / diagnosis
  • Pyruvate Metabolism, Inborn Errors* / genetics
  • Thrombocytopenia, Neonatal Alloimmune*

Substances

  • Pyruvate Kinase

Supplementary concepts

  • Pyruvate Kinase Deficiency of Red Cells